Kazia Therapeutics Limited (KZIA)

NASDAQ: KZIA · Real-Time Price · USD

8.11

-0.41 (-4.81%)

At close: Mar 11, 2026, 4:00 PM EDT

8.10

-0.01 (-0.12%)

After-hours: Mar 11, 2026, 5:03 PM EDT

Kazia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 11, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Cap	88	14	11	37	82	183
Market Cap Growth	2947.21%	33.16%	-71.18%	-54.61%	-55.23%	305.89%
Enterprise Value	83.06	8.7	9.26	37.1	81.75	182.58
Last Close Price	8.11	6.27	11.45	58.00	210.00	493.00
PE Ratio	-	-0.50	-0.34	-1.55	-3.23	-18.37
PS Ratio	71.42	5.55	3.07	26451.36	-	-
PB Ratio	-	-1.22	-0.76	-	-	-
P/TBV Ratio	-1.07	-0.83	-0.60	-	-	-
P/FCF Ratio	-	-0.76	-0.80	-1.75	-	-
P/OCF Ratio	-	-0.76	-0.80	-1.75	-	-
EV/Sales Ratio	69.26	3.39	2.66	26451.36	-	-
EV/EBITDA Ratio	-	-0.23	-0.25	-1.19	-	-
EV/EBIT Ratio	-	-0.22	-0.23	-1.10	-	-
EV/FCF Ratio	-	-0.47	-0.69	-1.75	-	-
Debt / Equity Ratio	-0.05	-0.05	-0.06	-	-	-
Debt / EBITDA Ratio	-0.01	-0.01	-0.02	-	-	-
Debt / FCF Ratio	-0.03	-0.03	-0.07	-	-	-
Net Debt / Equity Ratio	0.48	0.48	0.10	-	-	-
Net Debt / EBITDA Ratio	0.15	0.15	0.04	-	-	-
Net Debt / FCF Ratio	0.30	0.30	0.11	-	-	-
Asset Turnover	0.60	0.13	0.23	-	-	-
Quick Ratio	0.32	0.32	0.22	-	-	-
Current Ratio	0.35	0.35	0.24	-	-	-
Return on Equity (ROE)	498.78%	226.03%	534.65%	-	-	-
Return on Assets (ROA)	-839.78%	-184.11%	-261.08%	-	-	-
Return on Invested Capital (ROIC)	578.99%	1185.08%	-1253.42%	-	-	-
Return on Capital Employed (ROCE)	690.59%	452.25%	1351.47%	-	-	-
Earnings Yield	-15.85%	-198.32%	-296.56%	-64.50%	-31.01%	-5.44%
FCF Yield	-11.13%	-130.82%	-125.70%	-57.30%	0.00%	0.00%
Buyback Yield / Dilution	-103.59%	-157.46%	-73.21%	-49.04%	0.00%	0.00%

Updated Nov 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q